Abstract:

Abstract Introduction: In this study, we aimed to discuss the transfusion-associated costs in view of transfusion practice in the pediatric intensive care unit (PICU) by considering previously well-defined indications of blood transfusions and the evidence-based evaluation for transfusion decision-making in pediatric patients. Materials and Methods: During a year period (January 2017-December 2017) 76 patients, receiving transfusion with blood components along the stay in PICU were included in the study. Transfusion associated costs and total costs for healthcare services for children treated in PICU was collected by using Hospital Information System. Transfusion-associated costs depending on the supplies (such as sets for blood transfusion and apheresis), immunohematological tests and blood transfusion procedures were considered individually and the cost of transfusion was estimated for each patient which was proportioned to the total cost of healthcare services consequently. Results: The proportion of transfusion-associated cost to total cost of healthcare services was found as 3,24%. The medians for hospital cost and transfusion associated cost were 5478.76 euros (IQR=11280.02) and 130.57 euros (IQR=354.86), respectively. A significant strong positive corelation between numbers of transfusions and hospitalization cost of PICU was detected (r:0.674, p<0.01). In our study, although the median values of the patients administered with split blood were lower, no significant difference was found. Conclusion: There are no studies evaluating blood transfusions and costs in pediatric intensive care units in Turkey. More detailed studies are needed to examine transfusion costs and the diversity of blood product transfusions in intensive care units.

Keywords: